FOPAL Trademark

Trademark Overview


On Friday, October 7, 2022, a trademark application was filed for FOPAL with the United States Patent and Trademark Office. The USPTO has given the FOPAL trademark a serial number of 97623963. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Tuesday, February 27, 2024. This trademark is owned by Clementia Pharmaceuticals Inc.. The FOPAL trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Maintaining a registry of patient data and medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; conducting business and market research surveys in the fields of pharmaceuticals and clinical trials

Providing an online computer database featuring a compilation of medical information and patient records being medical information; medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; medical assistance services, namely, providing support in the observation, monitoring, adherence and medical treatments on patients; health assessment services, namely, conducting health-related surveys and questionnaires that produce medical treatment information; conducting medical information surveys and questionnaires in the fields of disease and treatment, namely, conducting health surveys of patients with Fibrodysplasia ossificans progressiva (FOP) disease for medical purposes

Providing a website featuring medical and scientific educational information in the fields of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of Fibrodysplasia ossificans progressiva (FOP) disease and treatment
fopal

General Information


Serial Number97623963
Word MarkFOPAL
Filing DateFriday, October 7, 2022
Status651 - SUSPENSION INQUIRY - MAILED
Status DateTuesday, February 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the design of a butterfly with two sets of two overlapping wings in yellow and orange shading to the left and to the right of the body of the butterfly which is created by the negative space between the left and right sets of wings. All of the butterfly design appears to the right of the stylized blue word "FOPAL". The white in the drawing represents background and is not a feature of the mark.
Indication of Colors claimedThe color(s) yellow, orange, and blue is/are claimed as a feature of the mark.
Goods and ServicesMaintaining a registry of patient data and medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; conducting business and market research surveys in the fields of pharmaceuticals and clinical trials
Goods and ServicesProviding an online computer database featuring a compilation of medical information and patient records being medical information; medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; medical assistance services, namely, providing support in the observation, monitoring, adherence and medical treatments on patients; health assessment services, namely, conducting health-related surveys and questionnaires that produce medical treatment information; conducting medical information surveys and questionnaires in the fields of disease and treatment, namely, conducting health surveys of patients with Fibrodysplasia ossificans progressiva (FOP) disease for medical purposes
Goods and ServicesProviding a website featuring medical and scientific educational information in the fields of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of Fibrodysplasia ossificans progressiva (FOP) disease and treatment

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, October 24, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 24, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 24, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameClementia Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMontreal, Quebec H3B2V6
CA

Trademark Events


Event DateEvent Description
Tuesday, February 27, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, February 27, 2024INQUIRY TO SUSPENSION E-MAILED
Tuesday, February 27, 2024SUSPENSION INQUIRY WRITTEN
Wednesday, February 14, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, December 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 19, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 19, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 11, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 11, 2023LETTER OF SUSPENSION E-MAILED
Friday, August 11, 2023SUSPENSION LETTER WRITTEN
Thursday, August 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 11, 2023NON-FINAL ACTION E-MAILED
Thursday, May 11, 2023NON-FINAL ACTION WRITTEN
Monday, May 8, 2023ASSIGNED TO EXAMINER
Tuesday, October 25, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, October 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 11, 2022NEW APPLICATION ENTERED